Magnetic Beads for Rapid Extracellular Vesicle Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating extracellular vesicles (EVs) are laborious, time-consuming, and inefficient, with ultracentrifugation being the gold standard but still plagued by issues like labor intensity, sample volume requirements, purity concerns, and contamination, while alternative methods face challenges such as chemical agent interference and high costs.
Innovation Solution
A stationary phase functionalized with Ni2+ or Al3+ cations, providing a positive net charge, is used for rapid and efficient isolation of EVs, allowing for the simultaneous capture of exosomes and microvesicles, with a method that involves suspending beads in a saline solution at physiological pH and using chelating agents for elution, reducing processing time and sample damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ultracentrifugation is used for EV isolation, then isolation effectiveness is improved, but processing time and labor intensity increase significantly
Solution Approach 1:
The patent replaces the mechanical ultracentrifugation system with a magnetic field-based separation system. Magnetic beads functionalized with specific ligands capture EVs through magnetic interaction, allowing separation via magnetic field application rather than high-speed rotation. This substitution reduces processing time from hours to minutes while maintaining isolation effectiveness.
Solution Approach 2:
The patent introduces magnetic beads as an intermediary carrier between the EVs and the separation process. These beads are functionalized with ligands that specifically bind to EV surface markers, serving as a mediator that facilitates capture and magnetic field-responsive separation. This intermediary approach enables rapid isolation without requiring prolonged ultracentrifugation.
2Reliability
If ultracentrifugation is used for EV isolation, then isolation effectiveness is improved, but sample volume requirements increase and purity decreases
Solution Approach 1:
The patent applies local quality by functionalizing magnetic beads with specific ligands that recognize and bind to particular EV surface markers. This localized specificity ensures that only target EVs are captured with high affinity, improving purity by preventing co-isolation of non-target particles and protein aggregates that commonly contaminate ultracentrifugation samples.
Solution Approach 2:
The patent changes the separation parameter from density-based (ultracentrifugation) to magnetic field-based separation. This parameter change allows for more precise control over the isolation process, enabling better purity through specific magnetic bead-EV interactions while reducing the sample volume needed for effective separation.
3Productivity
If chemical agents are used for EV precipitation, then isolation speed is improved, but EV integrity and composition are compromised
Solution Approach 1:
The patent replaces chemical precipitation agents with a magnetic field-based physical separation system. Magnetic beads functionalized with EV-binding ligands capture EVs through specific molecular recognition, followed by magnetic field-driven separation. This eliminates the need for chemical agents that could compromise EV integrity, while maintaining rapid isolation speed through efficient magnetic separation.
Solution Approach 2:
The patent uses disposable magnetic beads that can be directly added to samples for capture and then discarded after separation. This single-use approach eliminates the need for chemical agents and extensive washing steps, preserving EV integrity while achieving rapid isolation. The beads are designed for one-time use, avoiding contamination and degradation issues.
4Measurement precision
If immunoprecipitation is used for EV isolation, then specificity is improved, but cost increases due to antibody requirements
Solution Approach 1:
The patent replaces expensive antibodies with cost-effective magnetic beads functionalized with ligands that specifically recognize EV surface markers. These beads can be synthesized at lower cost and used as disposable single-use reagents, maintaining high specificity for EV isolation while significantly reducing the overall cost of the isolation process compared to antibody-based immunoprecipitation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves rapid EV isolation in under 60 minutes with high recovery rates, stability, and purity, and can be adapted to various sample volumes, making it more efficient and versatile than traditional ultracentrifugation, while avoiding the use of hydrophobic polymers and maintaining EV integrity.
Implementation Method 1
A stationary phase functionalized with Ni2+ or Al3+ cations, providing a positive net charge, is used for rapid and efficient isolation of EVs
Implementation Method 2
using chelating agents for elution
Data Source
Figure 1
Figure 2A~2C
Figure 3A
AI summary
The present invention describes a method for isolating extracellular vesicles (EVs) from different biological fluids, said nickel-based isolation method (NBI) is fast, scalable and allows for the purification of dimensionally heterogeneous EVs at physiological pH, preserving their integrity and stability in solution.